Sage Journals: Discover world-class research

Abstract

Background

Hypovascular pancreatic neuroendocrine tumor is usually misdiagnosed as pancreatic ductal adenocarcinoma.

Purpose

To investigate the value of texture analysis in differentiating hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma on contrast-enhanced computed tomography (CT) images.

Material and Methods

Twenty-one patients with hypovascular pancreatic neuroendocrine tumors and 63 patients with pancreatic ductal adenocarcinomas were included in this study. All patients underwent preoperative unenhanced and dynamic contrast-enhanced CT examinations. Two radiologists independently and manually contoured the region of interest of each lesion using texture analysis software on pancreatic parenchymal and portal phase CT images. Multivariate logistic regression analysis was performed to identify significant features to differentiate hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas. Receiver operating characteristic curve analysis was performed to ascertain diagnostic ability.

Results

The following CT texture features were obtained to differentiate hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: RMS (root mean square) (odds ratio [OR] = 0.50, P<0.001), Quantile50 (OR = 1.83, P<0.001), and sumAverage (OR = 0.92, P=0.007) in parenchymal images and “contrast” in portal phase images (OR = 6.08, P<0.001). The areas under the curves were 0.76 for RMS (sensitivity = 0.75, specificity = 0.67), 0.73 for Quantile50 (sensitivity = 0.60, specificity = 0.77), 0.70 for sumAverage (sensitivity = 0.65, specificity = 0.82), 0.85 for the combined texture features (sensitivity = 0.77, specificity = 0.85).

Conclusion

CT texture analysis may be helpful to differentiate hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas. The three combined texture features showed acceptable diagnostic performance.

Keywords

Pancreatic ductal adenocarcinoma pancreatic neuroendocrine tumor computed tomography texture analysis hypovascular

Get full access to this article

View all access options for this article.

References

Öberg

Eriksson

Endocrine tumours of the pancreas.

Best Pract Res Clin Gastroenterol 2005; 19:753–781.

Baur

Pavel

Prasad

, et al. Diagnostic imaging of pancreatic neuroendocrine neoplasms (pNEN): tumor detection, staging, prognosis, and response to treatment. Acta Radiol 2016; 57:260–270.

Lotfalizadeh

Ronot

Wagner

, et al. Prediction of pancreatic neuroendocrine tumour grade with MR imaging features: added value of diffusion-weighted imaging. Eur Radiol 2017; 27:1748–1759.

Kim

Hong

JY.

Recent updates on grading and classification of neuroendocrine tumors.

Ann Diagn Pathol 2017; 29:11–16.

Choi

Kim

, et al. Pancreatic neuroendocrine tumor: prediction of the tumor grade using CT findings and computerized texture analysis. Acta Radiol 2018; 59:383–392.

Kim

, et al. Neuroendocrine neoplasms of the pancreas at dynamic enhanced CT: comparison between grade 3 neuroendocrine carcinoma and grade 1/2 neuroendocrine tumour. Eur Radiol 2015; 25:1375–1383.

Kimura

Miyamoto

Fukuya

, et al. Neuroendocrine carcinoma of the pancreas with similar genetic alterations to invasive ductal adenocarcinoma. Clin J Gastroenterol 2016; 9:261–265.

Raymond

Dahan

Raoul

, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med 2011; 364:501–513.

Pompa

Morano

Jeurkar

, et al. Complete response after treatment with neoadjuvant chemoradiation with prolonged chemotherapy for locally advanced, unresectable adenocarcinoma of the pancreas. Case Rep Oncol Med 2017;2017:7834702.

10.

Guo C, Chen X, Wang Z, et al. Differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma using magnetic resonance imaging: The value of contrast-enhanced and diffusion weighted imaging. Oncotarget 2017;8:42962–42973.

11.

Jeon

Lee

Joo

, et al. Nonhypervascular pancreatic neuroendocrine tumors: differential diagnosis from pancreatic ductal adenocarcinomas at MR imaging-retrospective cross-sectional study. Radiology 2017; 284:77–87.

12.

Karmazanovsky

Belousova

Schima

, et al. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma. Eur J Radiol 2019; 110:66–73.

13.

Lubner

Smith

Sandrasegaran

, et al. CT texture analysis: definitions, applications, biologic correlates, and challenges. Radiographics 2017; 37:1483–1503.

14.

Guo C, Zhuge X, Wang Q, et al. The differentiation of pancreatic neuroendocrine carcinoma from pancreatic ductal adenocarcinoma: the values of CT imaging features and texture analysis. Cancer Imaging 2018;18:37.

15.

Liang

, et al. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers. Cancer Med 2018; 7:4924–4931.

16.

Kim

Eun

Kim

, et al. Pancreatic neuroendocrine tumour (PNET): Staging accuracy of MDCT and its diagnostic performance for the differentiation of PNET with uncommon CT findings from pancreatic adenocarcinoma. Eur Radiol 2016; 26:1338–1347.

17.

Davnall

Yip

Ljungqvist

, et al. Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 2012; 3:573–589.

18.

Kim

Lim

, et al. Breast cancer heterogeneity: MR imaging texture analysis and survival outcomes. Radiology 2017; 282:665–675.

19.

Hodgdon

McInnes

Schieda

, et al. Can quantitative CT texture analysis be used to differentiate fat-poor renal angiomyolipoma from renal cell carcinoma on unenhanced CT images? Radiology 2015; 276:787–796.

20.

Bayanati

E Thornhill

Souza

, et al. Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol 2015; 25:480–487.

21.

Shindo

Fukukura

Umanodan

, et al. Histogram analysis of apparent diffusion coefficient in differentiating pancreatic adenocarcinoma and neuroendocrine tumor. Medicine 2016; 95:e2574.

22.

Chakraborty

Midya

Gazit

, et al. CT radiomics to predict high-risk intraductal papillary mucinous neoplasms of the pancreas. Med Phys 2018; 45:5019–5029.

23.

Yue

Osipov

Fraass

, et al. Identifying prognostic intratumor heterogeneity using pre- and post-radiotherapy 18F-FDG PET images for pancreatic cancer patients. J Gastrointest Oncol 2017; 8:127–138.

24.

Cui

Song

Pollom

, et al. Quantitative analysis of (18)F-fluorodeoxyglucose positron emission tomography identifies novel prognostic imaging biomarkers in locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy. Int J Radiat Oncol Biol Phys 2016; 96:102–109.

25.

Ahn

Kim

Park

, et al. Prediction of the therapeutic response after FOLFOX and FOLFIRI treatment for patients with liver metastasis from colorectal cancer using computerized CT texture analysis. Eur J Radiol 2016; 85:1867–1874.

26.

Sandrasegaran

Lin

Asare-Sawiri

, et al. CT texture analysis of pancreatic cancer. Eur Radiol 2018; 29:1067–1073.

27.

Yun

Kim

Lee

, et al. Tumor heterogeneity of pancreas head cancer assessed by CT texture analysis: association with survival outcomes after curative resection. Sci Rep 2018; 8:7226.

28.

Digumarthy

Padole

Lo Gullo

, et al. CT texture analysis of histologically proven benign and malignant lung lesions. Medicine 2018; 97:e11172.

29.

Liu

, et al. Application of CT texture analysis in predicting histopathological characteristics of gastric cancers. Eur Radiol 2017; 27:4951–4959.

30.

Canellas

Mehrkhani

Patino

, et al. Characterization of portal vein thrombosis (neoplastic versus bland) on CT images using software-based texture analysis and thrombus density (Hounsfield Units). AJR Am J Roentgenol 2016; 207:W81–W87.

31.

Hanania

Bantis

Feng

, et al. Quantitative imaging to evaluate malignant potential of IPMNs. Oncotarget 2016; 7:85776–85784.

32.

Rodallec

Vilgrain

Couvelard

, et al. Endocrine pancreatic tumours and helical CT: contrast enhancement is correlated with microvascular density, histoprognostic factors and survival. Pancreatology 2006; 6:77–85.

33.

d’Assignies